Alnylam Pharmaceuticals
ALNY
#624
Rank
โ‚ฌ30.89 B
Marketcap
238,64ย โ‚ฌ
Share price
-0.16%
Change (1 day)
66.88%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company